Medico Remedies has secured a substantial international order valued at approximately Rs 13.38 crore, equivalent to $1.41 million, from PROMESE/CAL in the Dominican Republic. This significant contract involves the supply of critical pharmaceutical products, marking a notable addition to the company’s export portfolio. The deal highlights the Indian manufacturer’s expanding presence in global healthcare markets.
Order Specifics
The Mumbai-based pharmaceutical manufacturer will provide a diverse range of essential formulations, including tablets, capsules, and dry syrups. Medico Remedies is committed to completing the full order supply within a strict timeframe of 3 months from the date of securing the contract. This rapid turnaround aligns with urgent supply chain requirements.
Key Order Details
- Order Value: $1.41 million (approximately Rs 13.38 crore)
- Recipient: PROMESE/CAL, Dominican Republic
- Products: Tablets, Capsules, Dry Syrups
- Completion Timeline: Within 3 months
Recipient’s Mandate
PROMESE/CAL, officially known as Programa de Medicamentos Esenciales y Central de Logistica, plays a crucial role in the Dominican Republic’s healthcare infrastructure. This governmental entity is directly responsible for the centralized purchase and subsequent distribution of medicines, health supplies, and laboratory reagents. Its mandate is to efficiently meet the demand of the National Public Health System across the country, ensuring public access to vital medical necessities.
Medico Remedies’ Market Position
As a prominent pharmaceutical entity, Medico Remedies specializes in the manufacturing and export of various pharmaceutical formulations. Their established product range includes a wide array of tablets, capsules, and suspensions, catering to both domestic and international markets. This latest international order further underscores their capabilities in contributing to global health supply chains and solidifying their market position.